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                                        INTRODUCTION
Several   studies  of   Chronic   liver   disease    have     shown   that    arterial 
resistance  is   increased  in   cirrhotic patients  with ascites.It is related to  the  severity 
of   cirrhosis   and  to  the  renal  blood  flow,  aids in   predicting  progression  into 
hepatorenal  syndrome, and  is   available  as  a  prognostic factor.          
          The  Pulsatility  index  and  resistive  index  are  estimated  from 
blood flow velocity waveform analysis by Doppler studies .They are widely   accepted and used as 
valid indicators of renal vascular resistance. The  measurement of renal arterial resistance by doppler 
has been found                                                       to be useful in the study of organic and/or functional  
renal diseases                                                                                                                  in cirrhosis. In  
fact, elegant studies by Kew and colleagues have                                                            demonstrated  
that with the 133Xe washout technique that the renal blood flow is reduced even in well-compensated 
cirrhosis. Epstein et al. have also shown in their studies with the 133Xe washout technique and renal 
angiography that mean renal blood flow and renal cortical perfusion are  reduced in cirrhotic   patients. 
At   present the renal arterial resistance can be easily assessed by measuring the pulsatality index or 
resistive index    with    real-time  color  Doppler  studies of  renal arteries.
Patients with advanced chronic liver diseases often exhibit an abnormal hemodynamics that is 
characterized  by a  hyperdynamic  circulation  in  the  splanchnic  and  systemic  areas.  Schrier  et  al.  
proposed that these homodynamic changes might be due to peripheral hemovasodilatation, which could 
be recognized even in the very early stage of liver cirrhosis.
 The resulting Peripheral vasodilatation and the resulting reduced systemic vascular resistance 
might    contribute   to  the  reduced  effective    blood  flow estimated  from blood   flow  velocity 
waveform   analysis.
REVIEW OF LITERATURE
A    normal perfusion of  the   kidneys is crucial  to the maintenance of kidney functions, 
including  not  only  glomerular  filtration  rate  (GFR)  but  also  excretory  functions.  Under  normal 
physiological conditions,  the  renal    blood flow  is  maintained constant  through maintenance  of  a 
delicate   equilibrium   between  the  level  of  vasoconstrictors and   the   vasodilating   factors   acting 
on  the renal  circulation in   such  a  way     that any   increase   in   the   activity of   vasoconstrictor  
factors   is    rapidly  followed  by  a increase  in  compensatory    activation  of the     renal 
vasodilators, which helps to maintain  the renal perfusion within     normal limits. 
Renal hemodynamics in cirrhosis
It   has   been known   for many   years   that   such equilibrium in the renal circulation is of 
crucial importance in the setting of cirrhosis. In   some pathological instances, the equilibrium in the 
renal circulation can no longer be maintained, so that there is predominance of  vasoconstrictor factors 
and reduction in renal perfusion occurs. 
Investigations  performed  by several group of investigators      between    the   1950s  and 
1970s   using   specific    methods   to  assess    renal   plasma   flow   and    GFR   provided 
conclusive   evidence of  a   reduced  renal perfusion and GFR in  patients  with       advanced cirrhosis. 
They  have  also  conclusively  demonstrated  that  hepatorenal  syndrome  (HRS)  was  due  to  a 
vasoconstriction of the    renal circulation.
Later   studies   showed   that   patients   with even  less    advanced degree cirrhosis may also 
have some degree of renal vasoconstriction that tends   to   progress  over   time. While some of  the 
patients   with    pre-ascitic cirrhosis may   have  normal renal perfusion with no evidence of renal 
vasoconstriction,  Most of  the  patients with   ascites    show  a significant   reduction  of renal  blood 
flow and  glomerular filtration rate of variable    degrees   that usually  follow     other      abnormalities 
of   renal    function   such   as  sodium  and  solute-free   water  retention   that are    further  impaired 
by the  reduction     in    GFR.
MECHANISMS INVOLVED  IN THE REGULATION OF   RENAL HEMODYNAMICS  IN   CIRRHOSIS
The    exact   mechanisms   leading   to   renal   vasoconstriction   in cirrhosis are not completely 
known.  Several  factors,  including  disturbances  in  systemic  hemodynamics,  increased  activity  of 
vasoconstrictor systems, and   reduced   activity of vasodilator factors     acting   on     the   renal 
circulation  play   a   major   role.
The hemodynamic pattern of  patients  with  HRS   is characterized   by   hypervolemia,    high 
cardiac output,   low arterial pressure and total systemic vascular resistance, and marked activation of 
vasoconstrictor      systems. 
This   pattern of   highly      increased   renal   vascular   resistance in  the  setting   of  low   total 
systemic   vascular   resistance  and      compensatory   over activity of  vasoconstrictor  systems is 
very     characteristic     of    HRS,   although   not   exclusive,   as it may   be   observed in renal 
failure associated  with sepsis.
 By contrast, this pattern is markedly different from that of hypovolemia,   low cardiac output, 
and high total systemic vascular resistance    characteristic of most clinical conditions associated with 
renal hypo perfusion of   prerenal  origin. 
Rennin–Angiotensin–Aldosterone System
The  rennin–angiotensin–aldosterone  system  (RAAS)  was  the  first  major    vasoconstrictor 
system   to be investigated   as  a   possible   factor   responsible for renal vasoconstriction in cirrhosis.  
It is now   well   known   that the  activation of   RAAS  is particularly  intense   in   patients   with 
HRS  compared    with   patients   with   cirrhosis    and ascites without HRS. Moreover,   there   is   an  
inverse   relationship    between   the  plasma rennin activity (PRA), which estimates the activity of the 
RAAS, and the renal plasma flow and GFR.
 Further more the   indirect evidence   for    the   role    of      the   RAAS    in  the   pathogenesis  
of   renal vasoconstriction in   HRS   derives   from    clinical   studies showing    that    treatment    of 
patients   with  HRS with vasoconstrictor   drugs   and   albumin  or    transjugular    intrahepatic 
portosystemic   shunts (TIPS)    is  followed  by a marked improvement   of    renal plasma flow   and 
GFR   that  occurs together with  a marked  suppression (complete normalization  in some cases)of the 
increased  activity  of the rennin  angiotensin system. An   additional     piece of    evidence supporting 
the   role    of   the RAAS   in   the    pathogenesis   of   HRS   derives  from  the assessment   of  
evolution  of   the    temporal   relationship  between  the activation of the RAAS and the development 
of  renal failure in patients with  cirrhosis  and spontaneous bacterial peritonitis  In  this  condition, the 
development of HRS  is associated  with a striking   activation   of   the   RAAS. 
The  prompt  administration  of  intravenous  albumin also  prevents  the   activation  of  Rennin 
angiotensin aldosterone system during the infection and reduces the rate of development of HRS.
Interestingly,some of the recent studies have shown that the     beneficial effect of   albumin   in 
this    setting    is   perhaps   due   to an increase both in  total systemic  vascular   resistance   and    in 
cardiac output. Despite   all   this indirect   evidence, the definite confirmation of   a   role   for    the 
RAAS  in the pathogenesis of  renal  vasoconstriction   in  cirrhosis   has  not been provided and may 
be impossible. This would require the demonstration  that    the pharmacological  interruption of  the 
RAAS activity is ssociated with a reversal of the renal vasoconstriction. Unfortunately, this approach 
cannot    be   used   in   our clinical practice, as the blockade    of   the   activity   of    the    RAAS    is 
associated    with marked   arterial   hypotension   in    patients   with   cirrhosis    and ascites, due to the 
important effect of the RAAS in the maintenance of arterial pressure in this condition.
SYMPATHETIC NERVOUS SYSTEM
As occurs with the RAAS, in cases of advanced cirrhosis there is an increased activity of the 
sympathetic nervous system (SNS).The plasma concentration of vasoconstrictor norepinephrine (NE) 
in the systemic circulation, an index of the activity of the SNS, is increased   in most patients with 
ascites and normal or only slightly elevated in    patients without ascites.
Because the   SNS   is  one  of  the   powerful   vasoconstrictor   of    the renal circulation it  
would be  reasonable to  presume  that   the     increased renal  sympathetic  nervous activity in 
cirrhosis may  be important  factor in the pathogenesis of renal vasoconstriction and   also in HRS.
In  fact,  patients  with  HRS have  significantly  higher  plasma  levels  of  Norepinephrine  than 
cirrhotic patients with ascites without renal failure. The peripheral venous, arterial, and renal venous 
norepinephrine  levels  correlate  inversely  with  renal  blood.  Further  evidence  in  favor  of  the 
participation of the sympathetic  nervous system (SNS) in the pathogenesis  of the HRS is  that  the 
improvement  in  renal  blood  flow  and  GFR  after  pharmacological  treatment  with  vasoconstrictor 
drugs.TIPS placement in patients   with HRS is paralleled by a marked suppression of the activity of 
the SNS.
Unfortunately, in the same way as occurs with the RAAS,the inhibition of SNS   activity   in 
patients   with cirrhosis, using the   central   2-adrenergic clonidine, is associated with a marked fall in 
arterial pressure,   which  makes   it    impossible   to    test   directly   whether the SNS plays a major 
role in development of renal vasoconstriction   in cirrhosis .
One the recent observation that the administration of norepinephrine   intravenously together 
with albumin improves renal function in patients with Hepato renal syndrome has cast some doubt on 
the   role of the  endogenous   Norepinephrine   as   renal   vasoconstrictor in HRS. Nevertheless, it 
appears that exogenous NE produces renal vasoconstriction   only    when it is given   directly   into 
the renal artery or at doses that produce arterial hypertension.
NeuropeptideY is a neurotransmitter which has with a potent renal    vasoconstrictor effect that 
is  released  in  the  setting  of  a  marked  activation  of  the  SNS,  may  also  have  a  role  as    renal 
vasoconstrictor in cirrhosis, as peripheral plasma levels of NeuropeptideY are  increased   in   patients 
with   HRS  but  not  in  patients    with   ascites without    renal failure.
ENDOTHELINS
The   endothelin   family   comprises of three homologous peptides synthesized by a number of 
cell types, including the endothelial cells found in the systemic arterial and venous circulation.
The sinusoidal endothelial  cells and the hepatic stellate cells  found      liver,  and also the 
mesangial cells in kidney synthesize endothelins. The effects of Endothelins are mediated through two 
types of receptors, ETA and ETB, that exhibit distinct selectivity for ET isopeptides. The ETA receptor 
binds ET-1 and ET-2 with a higher affinity than ET-3, while ETB displays similar affinities for all 
three    isopeptides.
ETA is responsible for the vasoconstrictor effect of ETs, whereas the stimulation of ETB causes 
mainly vasodilatation through the activation of   nitric oxide (NO) and prostaglandins.
 ET    synthesized   by endothelial cells  is  thought to participate   in   the   regulation   of  
vascular   tone   by     acting   as a    paracrine    substance    on    the    underlying    vascular smooth 
muscle  cells.Most  of  the  patients  with  cirrhosis  of  liver  have  increased  circulating  levels  of 
endothelins(ET).Because of this and its marked vasoconstrictor effect, it has been proposed that ET 
contributes to the pathogenesis of renal vasoconstriction in cirrhosis. An   inverse relationship between 
plasma   levels   of ET and renal plasma flow   and GFR has been    demonstrated in   patients    with 
ascites   in  some   but  not  all    studies. However,   the   correlation between plasma levels of ET and 
renal function is weak   in most studies. Moreover there is no consistent relationship between    plasma 
levels of ET and the presence or absence of HRS.
Nevertheless, it  should be emphasized that  because endothelins are substance with a paracrine 
mode of  action, its plasma levels do not necessarily reflect levels of ET within the kidney, which so 
far    have   not been measured in human cirrhosis. Interestingly, improvement of renal function was 
reported in a small group of patient’s withHRS   after administration of BQ-123, selective antagonist of 
ETA receptors.
Unfortunately, this interesting finding has not been followed by   studies in larger groups of 
patients. In summary, a role for ET in   the      pathogenesis of HRS is possible but has not been 
demonstrated    thus  far.  This  confirmation  awaits  studies  using  newly  developed  ET  receptor 
antagonists in   patients with HRS.
ADENOSINE
Adenosine is an adenosine triphosphate (ATP) breakdown product      that causes vasodilatation 
in most of most of the vessels and   contributes to the metabolic control of organ perfusion. In contrast 
to  its vasodilatory effect in other organs, adenosine produces vasoconstriction in the renal vasculature. 
For this   reason, adenosine has been investigated as possible mediator of renal vasoconstriction in 
cirrhosis.Adenosine-1 receptors are present on the afferent   arteriole in the kidney and cells of the 
proximal  tubule and stimulation of these receptors inhibit  adenylcyclase activity,  resulting in renal 
vasoconstriction.It also causes sodium and water retention.
Adenosine-2  receptors  are  found  in  the  vasculature  of  the  systemic  circulation  and  their 
stimulation leads to vasodilatation.
The possible  roles  of  adenosine in  the pathogenesis  of renal     functional  abnormalities  in 
human cirrhosis have been assessed   using   several pharmacological approaches. These studies have 
shown that acute administration of methylxanthines, which act as nonspecific adenosine   antagonists, 
to   patients  with  cirrhosis and ascites is  associated   with   an    increase  in  the  renal blood  flow, 
Glomerular filtration rate and sodium and  water excretion  while the acute administration of   an 
adenosine-1 receptor antagonist  to patients with cirrhosis and ascites  induces  a  marked increase in 
sodium excretion and urine flow, without significant changes in renal hemodynamics.
Conversely, the acute administration of dipyridamole,a drug that    acts, at least in part,  by 
increasing the levels of adenosine in the extra cellular fluid due to inhibition of the cellular uptake of 
this   substance,  It is associated with renal vasoconstriction and increased sodium and water retention, 
particularly in those patients with ascites and increased activity of the RAAS Taken together, these 
results   indicate   that  adenosine  may have  a  role  in   renal  vasoconstriction  and  associated  renal 
abnormalities of cirrhosis.
Vasoconstrictor   Eicosanoids
In addition to synthesis of the vasodilating prostaglandins, the kidney also synthesizes a number 
of  vasoactive  eicosanoids  which  have  antinatriuretic  and/or  vasoconstrictor  activities.  The  renal 
production   of some of these eicosanoids with vasoconstrictor activity has also been     investigated 
in    patients    with   cirrhosis. It    was     first     suggested     that    HRS   could    be   the consequence 
of    an    imbalance    between    the     renal synthesis   of  vasodilator    and  vasoconstrictor  
eicosanoids based on the observation of reduced urinary excretion of prostaglandin E2 (PGE2) and 6-
keto-PGF1[a metabolite of prostaglandin I2 (PGI2)] and  increased  urinary excretion  of thromboxanes 
(i.e. TXB2)  in  patients   with  HRS. 
These findings however were not confirmed by any of subsequent investigations in which the 
urinary excretion of thrombaxane B2 in patients with HRS was found to be decreased. Moreover the 
inhibition of thromboxanes synthesis does not seem toimprove the renal function in these patients. 
The Eicosanoids other than thromboxanes with their vasoconstrictor   effect may potentially 
participate in the reduction of renal perfusion in   cirrhosis. The possible role of leukotrienes (LTs) in 
HRS   has    been    somehow overlooked.
Indeed,  studies  performed in  the  late  1980s and early 1990s  have  showed that  the  urinary 
excretion of LTE4, the major metabolite of   LTC4, andLTD4, and a useful measure of whole body 
production of      cysteinyl-leukotrienes, is elevated in HRS.
More  recently,the  concentration  of  the  vasoconstrictor   metabolite  20-
hydroxyeicosatetraenoicacid has been shown to be markedly    increased in the urine of patients with 
cirrhosis and ascites and inversely correlated with renal blood flow. 
Finally, the possible role of a family of newly discovered vasoactive peptides, prostaglandin F2-
like compounds, termed F2-isoprostanes, that are produced in vivo as products of free radical catalyzed 
lipid peroxidation independent of action of cyclooxygenase enzyme, has been   explored.
Patients with HRS have markedly increased plasma levels of F2-isoprostanes in the peripheral 
blood compared with those of    patients with decompensated liver disease without renal failure and 
patients with chronic renal failure without liver disease.
The  potential  role  of  all  these  vasoconstrictor  eicosanoids  in  the  pathogenesis  of  renal 
vasoconstriction in cirrhosis deserves further     investigation.
RENAL VASODILATORS
PROSTAGLANDINS
Prostaglandins  have  a  important  protective  effect  on   renal  function  in  pathophysiological 
conditions,  such  as  cirrhosis  with  ascites,which  associated  with  increased  activity   of    renal 
vasoconstrictor  systems    number  of    studies  in  patients   with  cirrhosis   have   provided   data 
supporting  the   existence of an  renal synthesis of  PGs.
Urinary excretion of the prostaglandin E2 and that of 6-keto-prostaglandin F1, which are the 
estimates the renal  synthesis  of  PGE2 and   PGI2,  respectively  are    increased in  patients  with 
cirrhosis and ascites without renal failure compared  with  healthy    subjects and  patients without 
ascites.
 Studies done with experimental  cirrhosis  have extended these    observations,  showing an 
increased  activity  and  expression  of  cytosolic  phospholipaseA2  and  cyclooxygenase  (COX),  the 
important two enzymes of the metabolic cascade of eicosanoids synthesis.
Out of the two isoforms of COX, only COX-2, the inducible isoform, is over expressed inthe 
kidneys of rats with carbon tetrachloride-induced cirrhosis, while the constitutive COX-1 is expressed 
normally. Nevertheless, COX-1 may be more important for the maintenance of optimal renal function. 
This is because selective inhibition of cox1  in      rats with  cirrhosis  is   associated  with  impairment 
in  renal function, while  the selective  inhibition  of   COX-2 isoenzyme  does not cause significant 
effects  on  renal function. 
No    validated data   are  available  on level of the   expression and the activities of   the 
different COX isoforms in human cirrhosis.  The supports for the important role of renal prostoglandins 
(PGs) in    the optimal maintenance of renal blood flow and GFR in cirrhosis with ascites are derived 
from studies assessing the effects of nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit 
renal PG synthesis.                               
The administration of classic NSAIDs, which cause a  nonselective inhibition of COX  activity, 
even  in  single doses, to cirrhotic  patients with ascites  causes a  profound decrease in renal blood flow 
and GFR, particularly  in  patients  with over  activity of  endogenous     vasoconstrictor  systems  .In 
clinical  practice these are actually   patients   with marked   sodium   retention   requiring  continuous 
administration    of      moderate   or    high     doses  of   diuretics. Therefore, NSAIDs should not be 
given to patients with cirrhosis and moderate or severe ascites. 
Classic NSAIDs have  little or   no   effect on   renal blood  flow    and   GFR    in    patients  
without    ascites   or    with   ascites    but   without     over activity   of    vasoconstrictor   systems.  
However, in    these     patients    the    administration   of  NSAIDs may    impair sodium   excretion 
and    lead to  the    development of ascites or increase ascites volume (P. Ginès, unpublished data).
Besides, inhibition of prostoglandins synthesis may also impair solute-free water excretion and 
lead to the development of dilutional     hyponatremia.
Therefore, the use of classic NSAIDs should be avoided in all     patients    with cirrhosis.  The 
available    information    on     the     renal    effects    of    drugs    that   inhibit    selectively   COX-2 
activity   in     patients   with   cirrhosis   and    ascites   is    very     limited. 
Two recent studies show that the administration of these drugs to     patients with cirrhosis and 
ascites is not associated with any    deleterious effects on renal function. However in these studies 
drugs were given for a short period of time.
Therefore, the effects of prolonged selective COX-2 inhibition on     renal function in cirrhosis 
with ascites remain to be established. Following the demonstration of an increased renal production of 
PGs  and their  participation  in  the  maintenance  of  renal  function  in    cirrhosis  and  ascites.It  was 
proposed that the low GFR   characteristic of HRS could be consequence of a spontaneous reduction 
in renal    PG   synthesis.
Several studies have reported that patients with HRS have lower      urinary excretion of PGE2 
and 6-keto-PGF1 than   do patients with      ascites without renal failure while other studies reported a 
normal  urinary excretion of  vasodilator  prostoglandins in  patients  with HRS.   Nevertheless,even a 
“normal” synthesis of Prostoglandins may below    the optimal level relative to he increased activity of 
vasoconstrictor systems present in cirrhosis.
Because   patients   with HRS have the greatest activation of renal vasoconstrictor systems, an 
imbalance between the production    vasoconstrictor systems and  the renal  production  of  vasodilator 
PGs could account, at least  in  part, for the  marked  reduction of    renal  blood flow  and   GFR  that 
occur  in   this  condition.
NATRIURETIC FACTORS
There is clear evidence for an increased  production of peptides    from the natriuretic peptide 
family (atrial natriuretic peptide,brain natriuretic peptide,and the Cnatriuretic peptide) in the setting of 
cirrhosis, particularly in patients  with ascites. Since the major     biological effect of these peptides is 
to increase the renal       excretion of sodium, a role of these peptides in the pathogenesis      of sodium 
retention in cirrhosis has been proposed.
Because these peptides also have also vasodilator properties, they    could participate in the 
pathogenesis  of  arterial  vasodilatation  and  maintenance  of  renal  perfusion.  Data  from  studies  in 
experimental       cirrhosis  suggests  that  they play an important  role  in  the  maintenance  of  renal 
perfusion and modulation   of RAAS activity.  In fact the selective blockade of the natriuretic peptide A 
and B   receptors causes renal vasoconstriction and increased PRA and  aldosterone levels in rats  with 
cirrhosis  and ascites.
No data are available on the effects of inhibition or antagonism of natriuretic peptides in human 
cirrhosis. Therefore the possible role of these peptides to counteract the activity of renal vasoconstrictor 
systems remains speculative.
NITRIC OXIDE
NO has been extensively studied as potential mediator of arterial    vasodilatation in cirrhosis. 
There is experimental evidence indicating     that the production of NO is increased in the kidney of 
rats with cirrhosis, because kidneys from cirrhotic rats have an enhanced    endothelium-dependent 
vasodilator response compared with control animals and infusion of L-arginine, the precursor of NO 
causes  a  greater  increase  in  renal  perfusion  in  cirrhotic  rats  compared  with  controls.  Increased 
expression of NO synthase (NOS) in kidney from cirrhotic rats has been demonstrated in two studies, 
but there is disagreement on the isoforms of NOS responsible for  the increased synthesis of NO.
The importance of this increased renal production of NO in    experimental cirrhosis is not 
known. Inhibition of NO in this setting    does not cause renal hypoperfusion, but it is associated with 
an increased synthesis of PGs.By contrast, simultaneous inhibition of NO and PGs results in marked 
renal  vasoconstriction.  Therefore  it   is  possible  that  NO interacts  with  PGs  to  maintain  the  renal 
hemodynamics in experimental cirrhosis.
No information is available on renal NO production and its      possible role in the modulation 
of renal function in human cirrhosis.
RENAL KALLIKREIN–KININ SYSTEM
Some studies have reported that urinary kallikrein excretion is     increased in patients with 
ascites without renal failure and reduced      in patients with HRS and correlates directly with GFR, 
suggesting    the role of renal kallikrein–kinin system. It is an intrarenal system with    vasodilator and 
natriuretic activities, which may contribute to the    maintenance of renal hemodynamics in cirrhosis.
Other investigations however have found reduced urinary kallikrein excretion in patients with 
ascites.Much more specific methods to evaluate the activity of the kallikrein–kinin system are needed 
before the role of this system in the homeostasis of renal function in cirrhosis can be defined.
PATHOGENESIS OF HEPATORENAL SYNDROME
The pathophysiological hallmark of HRS is a severe vasoconstriction of the renal circulation. 
Any theory that aim’s at explaining the pathogenesis of HRS should provide an explanation for the 
existence of a marked renal vasoconstriction in the setting of a very pronounced arterial under filling in 
the  systemic circulation  which  is  characteristic  of  cirrhosis.  In  addition,  it  should also provide an 
explanation for the continuum from compensated cirrhosis with normal or near-normal renal function 
to decompensated cirrhosis with ascites and sodium retention, severely decompensated cirrhosis with 
severe  ascites  and  spontaneous  dilutional  hyponatremia  and  finally  renal  failure  due  to  renal 
vasoconstriction (i.e. HRS).
The theory that best fits with the observed alterations in the renal and circulatory function in 
HRS is  the  arterial  vasodilatation  theory,  which  proposes  that  HRS is  the  result  of  the  effect  of 
vasoconstrictor  systems  acting  on  the  renal  circulation.  These  constrictor  systems  are  activated  as 
homeostatic mechanisms to counteract the extreme under filling of the arterial circulation and thus to 
maintain arterial pressure. As a result of this increased activity of the vasoconstrictor systems, renal 
perfusion and GFR are markedly reduced but tubular function is preserved. 
This is different from what occurs in acute tubular necrosis (ATN), in which renal failure is 
associated with a markedly impaired tubular function. The activated vasoconstrictor systems are also 
responsible for the sodium retention and impaired solute-free water excretion that occur in the setting 
of HRS .Most available data suggest that arterial under filling is due to a marked vasodilatation of the 
splanchnic  circulation  related  to  an  increased  splanchnic  production  of  vasodilator  substances, 
particularly NO  Sodium retention and  ascites and edema formation would develop as a consequence 
of homeostatic  activation of vasoconstrictor and antinatriuretic mechanisms acting on the systemic 
circulation  and  kidneys  to  maintain  effective  arterial  blood  volume  constant.  In  initial  phases  of 
decompensated  cirrhosis,  renal  perfusion  would  be  maintained  within  normal  levels  despite  the 
activation of  potent  vasoconstrictor  factors  because  of  an increased  synthesis  of  renal  vasodilators 
(mainly prostaglandins).
In this setting, the equilibrium between vasoconstrictor and vasodilator factors is very delicate 
and  the  kidney is  very  sensitive  to  further  impairment  in  the  systemic  arterial  circulation  and/or 
decreases in the renal production of vasodilator factors.
Therefore, any impairment in arterial under filling, either spontaneous, due to progression of 
splanchnic  vasodilatation,  or  triggered  by  specific  clinical  circumstances  (i.e.  bacterial  infections, 
especially spontaneous bacterial  peritonitis,  large-volume paracentesis  without plasma expansion or 
gastrointestinal bleeding) would result in a further activation of vasoconstrictor systems.The splanchnic 
area would escape from the effect of vasoconstrictors probably because of a markedly enhanced local 
production of vasodilators.
The recent observation by several groups that the administration of vasoconstrictor drugs with a 
preferential effect on the splanchnic circulation, such as ornipresin or terlipressin,together with albumin 
administration  improves  renal  function  in  patients  with  HRS  is  consistent  with  series  of  events 
proposed by the arterial vasodilatation hypothesis. 
Although  arterial  under  filling  in  HRS  is  mainly  due  to  splanchnic  arterial  vasodilatation 
causing an abnormal distribution of arterial blood volume, recent evidence suggests that an impaired 
cardiac function due to cirrhotic cardiomyopathy may also play a role.
Although cardiac output is high in most patients with HRS, it may be low relative to markedly 
dilated splanchnic vascular bed. It has been proposed that a reduction in cardiac output from the high 
values characteristic of cirrhosis with ascites to normal or moderately reduced values may trigger the 
development  of  HRS,  particularly  type  1.The  possible  role  of  impaired  cardiac  function  in  the 
pathogenesis  of  HRS should  be  investigated  further.  Vasoconstriction  of  the  renal  circulation  is  a 
common finding in patients with cirrhosis.It may already occur in early stages of the disease, but it 
becomes more marked over time. In most patients, marked vasoconstriction of the renal circulation 
occurs after patients have developed an impaired excretion of sodium and solute-free water (which are 
manifested clinically by development of ascites and dilutional hyponatremia, respectively).
It is now well established that vasoconstriction of the renal circulation occurs as a consequence 
of a marked impairment of the systemic arterial circulation.It is characterized by arterial vasodilatation, 
which  predominates  in  the  splanchnic  area,  and  compensatory  activation  of  the  endogenous 
vasoconstrictor  systems.  These  activated  vasoconstrictor  systems  cause  an  effect  on  the 
kidneycirculation, whichis roughly proportionate to their degree of activation. 
Vasodilators of renal and extra renal origin are subsequently activated to compensate for the 
increased activity of  vasoconstrictor  factors in  the kidney.  This  situation results  in  a  very delicate 
equilibrium in the renal circulation, which is then very sensitive to changes in the activity of vasoactive 
factors. Either an increase in the activity of vasoconstrictor factors (generally as a result of a further 
impairment in the systemic arterial circulation) or a decrease in the activity of vasodilator factors may 
lead to the development of HRS, which is the extreme expression of renal vasoconstriction in the 
kidney.
RENAL   DOPPLER ULTRASOUND
A series of articles published during  the past decade clearly indicated the potential of doppler 
sonography for  improving  the  sonographic  assessment  of  renal  dysfunction.  Changes  in  intrarenal 
arterial waveforms were shown to be associated with urinary obstruction, several  types of intrinsic 
renal disorders, and renal vascular    disease.
The    Doppler    resistive index (RI) = ([peaksystolicvelocity– end diastolic velocity] / peak 
systolic velocity) was advanced as a useful parameter for quantifying the alterations in renal   blood 
flow that may occur with renal disease.      
TECHNIQUE
Most studies describing the   potential use of   Doppler sonographic for evaluating renal disease 
have stressed the need for meticulous technique. The highest frequency probe that gives measurable 
waveforms should be preferentially used,  supplemented by color  or power Doppler  sonography as 
necessary  for  vessel  localization.  Arcuate  arteries  (at  the  corticomedullary  junction)  or  interlobar 
arteries (adjacent to medullary pyramids) are then  insonated  using    a 2- to4-mm  Doppler gate. 
Waveforms  should be optimized   for  measurement using the lowest  pulse repetition frequency 
without aliasing  (to maximize waveform size), the  highest  gain  without obscuring  background 
noise, and the lowest wall  filter.
About three to five reproducible waveforms from each kidney are    obtained, and the RIs from 
these waveforms are averaged to arrive at  mean RI values for each 
THEORY OF   RI  
The  earlier  failure  of  the  RI  to  become  a  meaningful  parameter  for     evaluating  kidney 
physiology  and  function  may  be  due  to  our  often       rudimentary  understanding  of  renal 
disease.Furthermore  Doppler     sonographic  analysis  of  renal  artery  waveforms  was  empirically 
applied to disease characterization before a full understanding of    the factors that affect the arterial 
waveform  (e.g.,  vascular  compliance,  vascular  résistance,  and  heart  rate)  was  obtained.Thus,this 
empiric  use of Doppler sonography gave  less than satisfactory  results. 
 For example,it was almost universally accepted in the early     Doppler literature that  the RI 
varied directly with changes  in   renal vascular resistance. In many reports, the both terms “resistive 
index” and “renal vascular resistance” are used   interchangeably.
Although the relationship between these factors and other     potentially confounding variables 
have  generally  not  been   considered.  A  series  of  in  vitro  experiments  recently  performed  at  the 
University of Michigan have convincingly shown the important  role  of vascular  compliance in RI 
analysis. Compliance is the rate of change of volume of a vessel as a function of pressure.
 Anyone who has observed a pulsating artery whose diameter    expands in systole and contracts 
in diastole has seen the visual     manifestation of the effect of compliance. In vitro experiments were 
performed to assess the impact of changes in vascular resistance     and compliance on the   RI.
The RI was dependent on the  vascular compliance and resistance,   becoming less and less 
dependent on resistance as the compliance     decreased, and being completely independent of vascular 
resistance  when compliance  was  zero.  In  another  in  vitro  study performed  by the  same  group of 
investigators, the RI was shown to decrease with  increases in the cross-sectional area of the distal 
arterial bed; this effect was independent of compliance and vascular resistance.
Ex vivo results, similar to in vitro results, were obtained in a series    of experiments performed 
at Albany Medical College. Rabbit  kidneys were perfused ex vivo using a pulsatile perfusion system 
(Fig. 3). Renal vascular resistance, systole, diastole, pulse pressure,  and pulse rate were controlled and 
monitored while the RI was simultaneously measured.
A linear relationship was seen between the RI and pharmacologically induced changes in renal 
vascular resistance. However, the RI increased only with very marked, likely nonphysiologic increases 
in renal vascular résistance. Those changes in the RI that were seen with intense vasoconstriction were 
only marginally greater than RI measurement     variability. The RI was also markedly affected by 
changes in driving    pulse      pressures, however. A linear relationship was shown between the pulse 
pressure index (systolic pressure – diastolic pressure / systolic pressure) and the RI.
                                     AIM OF THE STUDY
1. To calculate the renal arterial Resistive index, Pulsatility index in patients with chronic liver 
disease.
2. To calculate renal arterial RI index in patients with chronic liver disease and its correlation with 
severity of chronic Liver disease.
3. To study  the  usefulness  of  RI  as  a  noninvasive  predictor  of  response  to  diuretic 
therapy in chronic liver disease.
4. To study renal arterial resistive index and its association with esophageal varices in 
patients with chronic liver disease.
                  
METHODS AND MATERIALS
The study was conducted between January 2006 and May 2008 in Government 
peripheral hospital, Annanagar.The study was a prospective study.
INCLUSION CRITERIA
Patient  who were  diagnosed to  have  cirrhosis  by  combination  of      clinical, 
biochemical, endoscopic and histological features and who  are off    diuretics for two 
weeks. 
New patients who were diagnosed to have cirrhosis by combination           of 
Clinical, radiological, and histological features.
EXCLUSION CRITERIA
a. Patients with intrinsic renal disease, Diabetes mellitus, Hypertension.
b. Patients with active GI bleed, infections, malignancy.
c. Patients with CLD who had taken diuretic within a fortnight.
d. Patients   with    serum   creatinine > 1.4mg.                                                
Detailed history was taken from the patients and a complete physical examination 
of patients was carried out. In particular attention was paid to look for signs of liver cell 
failure   like  the  spider, palmar erythema, and parotid enlargement, palmar erythema, 
Duptyrene contractions.
A  careful  examination  of  abdomen  was  done  to  look  for  hepatomegaly  and 
spleenomegaly, ascites.Cardiovascular, Respiratory and Nervous system were examined. 
A complete hemogram, LFT, renal function were done. Doppler studies of renal arteries 
were done. OGD was done with in one day of admission.        
Doppler studies were performed in patients after overnight fasting. Doppler study 
was done using a duplex Doppler apparatus with a color Doppler sonographer and 3.75 
MHz convex transducer. The transducer was positioned below the costal margin in the 
dorsolateral  area  of  the  flanks.  The  intrarenal  artery  of  the  kidney  could  be  easily 
identified by color Doppler ultrasonography.
The sampling volume of the pulsed Doppler system was placed in the intralobar 
artery along the border of the medullary pyramids, and the blood velocity wave form 
was recorded.  The maximum systolic  velocity,  end diastolic  minimum velocity,  and 
mean  velocity  were  determined.  The  Pulsatility  index  and  resistive  index  were 
calculated according to the following formulae.        
Mean Systolic velocity – End Diastolic Minimum Velocity
PI =   
Mean velocity
Mean Systolic velocity – End Diastolic Minimum Velocity
RI =
End Diastolic Minimum Velocity
Patients  were  treated  with  salt restriction 50meq/d and diuretics          after 
Doppler  studies with combination of   Spironolactone and frusemide  starting with a 
smaller  dose and  increasing  dose  according  to  response. 
Body weight   was measured   daily. Satisfactory  Response   was  defined  as 
mean  body  weight  loss of two hundred   grams as defined   by  Neven Ljubicic  etal 
( Scandinavian  journal of  gastroenterology April 1998).
Mean body weight loss of less   than two hundred grams with 200mg/day with an 
intake of  spironolactone and 120mg/day of frusemide was defined as unsatisfactory 
response to diuretic therapy (resistant ascites).
Esophageal  varices  were    graded  according  to  Pacqet    classification  and 
Cirrhosis graded by Childs grading.             
CHILDS GRADING OF LIVER DISEASE
           A           B      C
S. Bilirubin                   
         <2mg  2-3mg >3mg
S.Albumin          >3.5mg  3-3.5mg   <3mg
Ascites          None  Easily 
controlled
Poorly 
controlled
Neurological 
disorder
         None  Minimal Coma
Nutrition          Excellent  Good Wasting
Child A    5-6       Child B    7-9           Child C 10-15
GRADING OF ESOPHAGEALVARICES
Grade 1:  Varices   are   small   and   straight. 
Grade 2:  Varices   are   tortuous   and     occupying   less than one third of    lumen.
Grade 3: Varices   occupying   more   than  one  third  of  the  esophageal 
lumen. 
Grade 4:  Varices    occluding    the    lumen of esophagus.
Data   was   entered    and    all    the     statistical   analysis   was   done Using 
stastistical   analysis    software   Epi Info 2.3.4   windows version           
Normal    values    were    taken from   previous studies   involving   normal 
subjects
 Normal values
RI----0.62+/- 0.05
PI----1.00+/- 0.12
                                              
RESULTS
A total of 57 subjects participated in the study. The mean age of  the patients was 
44, with a range from 30-75 years. Of the 57 patients, 44 were male and 13were  female.
DEMOGRAPHIC PROFILE
Age
Mean
49
Median 49
Standard deviation 12.4
Range 30 to 75
Sex Male 44 (77%)
Female 13 (23%)
Child A 12 (21%)
B 26 (46%)
C 19 (33%)
Based on clinical and data from investigations 12 patients were categorized    to 
Child A, 26 to child B, 19 to Child C.
HBV (35%) infection was found to be  the commonest     cause found in 20 
patients, alcohol abuse was seen in 18 (31%) patients, HCV (17.5%) were detected  in 
10 patients. Other causes include BCS,    PBC, AIH, unknown causes.
ETIOLOGY
ALCOHOL 18 (31%)
HBV 20(35%)
HCV 10(17.5%)
OTHERS  AND COMBINED 9(15%)
Resistive index and the Pulsatility index was found to be 0.72 with a  standard 
deviation of 0.06,1.48 with a standard deviation of 0.24 in  cirrhosis patients  which is 
higher than in  normal population.
RI   AND PI  IN CIRRHOSIS
R
I
Mean
0.72
Median 0.72
Mode 0.73
Standard deviation 0.06
Range 0.60to 0.85
% normal (0.62 ± 0.05) 13 (23%)
PI Mean 1.48
Median 1.40
Mode 1.40
Standard deviation 0.29
Range 0.99 to 2.20
% normal (1.00 ± 0.12) 5 (9%)
Of these patients only 13(23%) patients had RI in normal range.  while      only 
5(9%) patients have Pulsatility index in normal range.                                                   On 
subgroup analysis of patients in different grade of cirrhosis. 
RI IN DIFFERENT GRADES
Child grading
A
(n=12)
B
(n=26)
C
(n=19)
Mean 0.64 0.71 0.78
Median 0.65 0.71 0.78
Mode 0.65 0.73 0.76
Standard deviation 0.025 0.019 0.036
Range 0.60
to
0.68
0.67
to
0.73
0.71
to
0.85
% normal (0.62 ± 0.05) 11 (92%) 2 (8%) 0 (0)
Kruskal-Wallis H (equivalent to Chi square) =45.3; p< 0.001
The    mean value of    RI was found   to   be as    follows.
Child A ………..  0.64 with   standard deviation of 0.025.
Child B ………..   0.71 with standard deviation of   0.019.
Child C………..    0.78 with standard deviation of  0.036. 
      Among those 12 patients   in Childs A group    it was found 11(92%)  patients 
had  RI   in  the  normal Range. Only 2 out of 26 (8%) Grade B cirrhoses, none of 
patients in Child C had RI in the normal range.
Resistive  index  showed  a  significant   increase  With  increasing  severity  of 
cirrhosis.Kruskal-  Wallis  H value  was  calculated    to  study the correlation  between 
resistive index and severity of cirrhosis. It wasfoundto be 45.3 with a Pvalue< 0.0001 
which  is  statistically  significant.  The  mean  Pulsatality  index  was1.15  with  standard 
deviation of 0.086 in child A cirrhosis,1.38 with standard deviation   of 0.086 in Child 
Cirrhosis, 1.83 with standard deviation of 0.180.                               
PI   IN GRADES OF CIRRHOSIS
Mean 1.15 1.38 1.83
Median 1.16 1.38 1.78
Mode 1.20 1.40 1.69
Standard deviation 0.086 0.086 0.180
Range 0.99
to
1.30
1.29
to
1.55
1.60
to
1.69
% normal (1.00 ± 0.12) 5 (42%) 0 (0) 0(0)
Kruskal-Wallis H (equivalent to Chi square) =47.8; p < 0.001
Pulsatility index was within the normal range in 5 out of the 12 patients (42%) in 
Child A group while none of the 26 patients in ChildB, 19inChildC had PI in the normal 
range.Esophageal varices were seen in eight patients while 3 did not have varices in 
childA cirrhotic   patients.All the 3 patients who did not have esophageal varices had a 
normal resistive index.
OESOPHAGEAL VARICES BY RI LEVEL
RI level
No. of varices
NO 1 2 3 4 Total
Within normal range 3 6 3 0 1 13
Outside normal range 0 15 22 6 1 44
Total 3 21 25 6 2 57
 RI  value  and presence of  oesophageal  varices among ChildA graded cirrhosis 
patients  (N=8)  are  strongly  and  positively  correlated(correlation  coefficient  is 
0.67)However, this observation is based on just eight patients. This suggests a positive 
correlation between presence of esophageal varices and resistive index. 
Out of  the 57  patients in  this study 45 patients were treated with    diuretics.40 
(70%) patients responded to diuretics.while 5(9%)patients    did not respond to diuretics.
RESPONSE TO DIURETICS BY RI LEVEL            
RI level
Response to diuretics
Yes ; Respond to 
diuretics
Resistant to 
diuretics
Total
Within normal range 2 0 2
Outside normal range 38 5 43
Total 40 5 45
                      
38 out of 40 patients who had adequate response had RI outside normal range. 
While only 2 patients had RI in the normal range. Among the non  responder   all   the  5 
patients   RI  were   outside  normal  range.
RI level Mean (Standard deviation)
Respond to diuretics 0.73 (0.036)
 Resistant to diuretics 0.83 (0.016)
Kruskal-Wallis H = 13.2; p value=0.0003
The mean RI was 0.73(standard deviation of 0.036) and 0.83 (Standard deviation 
of 0.010) in diuretic responsive and non responsive group. Krushal –Wallis H value for 
correlation between mean RI and diuretic response was 13.2 with p value of 0.0003 
which is stastically significant.
DISCUSSION
This study was carried out in a tertiary level hospital. Most of the patients are 
from north Tamilnadu and few from   Andrapradesh. Mean age of the patients in this 
study was 49 +/- 12. Mean age of patients with cirrhosis in study by Joshi etal1 was 45 
which is similar to this study.
Out of 57 patients in this study 44(77%)   were male and13 (23%) were female. 
Male female ratio is 3:1. S.kSarin etal24 reported a similar sex distribution in their study. 
The causes of cirrhosis vary in different places.                                             
The most common cause of cirrhosis in this study was   Hepatitis B Virus (35%) 
infection  followed  by  ethanol  and  HepatitisC  Virus.Joshietal1have  reported  similar 
figure in their study HBV (30%), alcohol (20%), HCV (14%).  The   higher   number 
patients   in   this study    in alcohol group could be   due   to   referral bias.  
As all patients with History of alcohol abuse are referred from Institute of   mental 
health for evaluation of hepatocelluar function to our hospital.  Prevalence of HCV is 
comparable   in   both studies.              
Marota etal  2 and  Platt etal3 were among  first   authors   to   show   RI   is 
increased in  patients with nonazotemic functional renal failure   in addition to other 
causes  like  ATN,  renal arterial   thrombosis14,15,16.
Renal arterial vasoconstriction   is   said   to be   the   main   pathophysiology in 
volume overload. This was ascribed     to  high levels of  vasoconstrictors. N.Ljubicic 
etal20 showed that RI is   increased   in cirrhosis. Further   studies by Masohika Koda 19 
have shown that RI  also   increases  with   progressive  in  grading  of cirrhosis.
This  study  also   shows   a  similar  finding. The  mean  RI   value is 0.72 +/- 
0.06  and   PI   is   1.48+/-0.29  which  is     higher  than  normal  values 
( 0.57-0.67,0.88-1.12 ). Masohika Koda etal have also showed that this increasing value 
of  RI  is  associated   with  increasing  level  of  serum  vasoconstrictors 
rennin,aldosterone,and epinephrine.This study  also  shows  mean RI & PI  to increase 
with  increasing grade of  cirrhosis.
MEAN   RI   & PI   ARE
Grade RI PI
Child   A
Child   B
Child  C
0.64   +/-   0.025
0.71   +/-   0.019
0.78   +/-   0.036
1.15    +/-    0.086
1.38    +/-    0.086
1.38     +/-   0.180
                                          
Kruskal- Wallis  N   value   for correlation between  severity of cirrhosis and RI 
&  PI  values was   significant  with    a p value  of   <  0.001.
     Out of the 57 patients in this study patient  45 patients were treated with 
diuretics.  70%  responded  adequately  to    diuretics,  9percentof  patients  were  non 
responders  according  to  definition  of  Ljubicic20.The  prevalence  of  diuretic  resistant 
ascites is accepted to be  around 10%. Gatta etal 11 have reported a prevalence of 9% .A 
study by Perez –Ayuso25 also report a prevalence of 10%.
Definition used   in this   study   is   not   same as International    ascites    club 
definition. Sungaila etal10 have showed  patients  who do not   respond    to  200mg of 
spironolactone, and 120mg of frusemide are unlikely to    respond to dose escalation. 
Ljubicic  has  based  his definition on this   study .Further studies are needed to know if 
patients with inadequate   response represent the classical diuretic resistant ascites.          
This   study also shows that  a   high   value   of   RI is noninvasive predictor of 
inadequate response to ascites.However   this observation is based on a small cohort. 
Studies involving larger     sample is needed    to   confirm   this finding.
Analysis of ChildA cirrhosis subgroup shows that an elevated RI   value is seen 
in  patients  with  esophageal  varices.   Agostino  colli   etal 21  have  reported   this 
association in their study. This    is  an   important  observation  as   this    indicates 
renal   vasoconstriction    precede  development  of   ascites  in  cases  of  portal 
hypertension .RI could also   correlate with portal  hypertension.
Levy   etal 26 and  Schrier27 etal  havelso  reported   an  similar   observation    in 
their studies
CONCLUSION
1. Renal Resistive index and pulsatality index are abnormal in most of the patients with 
cirrhosis.
2. Renal Resistive index and the pulsalility index are increased even in patients with 
normal renal function tests.
3. Renal  Resistive  index  and  pulsatality  index  show  a  significant  and  a  positive 
correlation with increasing grade of   cirrhosis.
4. Renal  Resistive index is a invasive predictor  of response to diuretic treatment of 
ascites in cirrhosis.
5. A high level of RI correlates with presence of esophageal varices. 
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                                                          PROFOMA
 Name   of   the  patient:
 Address:  
Age/ sex:
Complaints:
a)Abdominal  distention.
b) Leg swelling.
c) Oliguria.
d) Jaundice.
e) Breathlessness.
f) Hematemesis  & malena
g) Alcohol   use
h) drug intake
Past  history:
H/O   renal disease
H/O   malignancy
H/O   DM/  HT/ IHD/ Malignancy.
                                     GENERAL  EXAMINATION:
Consiousness                                       vitals/  body weight 
Nourishment                                        signs  of  liver cell dysfunction.
Febrile                                                  Evidence   of   malnutrition
Pallor  and  icterus                                Lymph  nodes
 
Pedal  edema                                         Asterixsis 
Abdominal  examination
Hepatomagaly                                       Spleenomegaly
Ascites                                                   Abdominal  veins
Others  system:
CNS:
RS:
CVS
                         LABORATORY  INVESTIGATIONS
Complete hemogram
Liver  function  test:
S.bilirubin                                                             S.Proteins
SGOT                                                                   Albumin
SGPT                                                                     Globulin
ALP
Ultrasonogram abdomen & doppler
Endoscopy
    Response  to diuretics 
                        

